[Clinical studies on the effect of Regadrin of the VEB Berlin-Chemie in the treatment of essential hyperlipemias].
D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D008297:Male; D010654:Phenylbutyrates / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D010654:Phenylbutyrates; D014280:Triglycerides
Klinische Untersuchungen zur Wirksamkeit von Regadrin des VEB Berlin-Chemie in der Behandlung essentieller Hyperlipidämien.